Results 191 to 200 of about 5,262,545 (393)
Objective To evaluate the sensitivity of the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS), and to assess their ability to identify patients at risk of future pregnancy complications.
Francesca Ruffilli +10 more
wiley +1 more source
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
B. Neal +9 more
semanticscholar +1 more source
Biofabrication aims at providing innovative technologies and tools for the fabrication of tissue‐like constructs for tissue engineering and regenerative medicine applications. By integrating multiple biofabrication technologies, such as 3D (bio) printing with fiber fabrication methods, it would be more realistic to reconstruct native tissue's ...
Waseem Kitana +2 more
wiley +1 more source
Precursor‐ and solvent‐mediated synthesis yields four Cu3(HHTP)2 morphologies with distinct physicochemical, sorption, and sensing properties toward SO2. Uptake capacities correlate with BET surface area, while sensing performance scales with particle aspect ratio.
Patrick Damacet +5 more
wiley +1 more source
Background Azotemia is common in cats with congestive heart failure (CHF) and might be exacerbated by diuretic therapy. Hypothesis/Objectives Determine frequency, risk factors, and survival impact of progressive azotemia in cats treated for CHF.
Sarah Rogg +6 more
doaj +1 more source
Vascular Biomarkers in the Prediction of Clinical Cardiovascular Disease [PDF]
Mary J. Roman +6 more
openalex +1 more source
Handgrip Strength Is an Independent Predictor of Cardiovascular Outcomes in Diabetes Mellitus
Yoshinobu MORIKAWA +5 more
openalex +2 more sources
An oral nanoplatform, MOP@T@D, which can maintain glucose homeostasis and restore islet β cells in diabetic rats is developed. It achieves efficient intestinal absorption and liver‐targeted delivery. The nanoparticle disintegrates only in response to hyperglycemia to release insulin on demand and provides antioxidant protection through selenoprotein ...
Chenxiao Chu +14 more
wiley +1 more source
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
B. Zinman +11 more
semanticscholar +1 more source

